These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The association of advanced glycation end-products with glutathione status. Sahin E, Göçmen AY, Koçak H, Tuncer M, Gümüslü S. Ann Clin Biochem; 2008 Jul; 45(Pt 4):369-74. PubMed ID: 18583621 [Abstract] [Full Text] [Related]
23. Inflammatory status in patients with chronic renal failure: the role of PTX3 and pro-inflammatory cytokines. Malaponte G, Libra M, Bevelacqua Y, Merito P, Fatuzzo P, Rapisarda F, Cristina M, Naselli G, Stivala F, Mazzarino MC, Castellino P. Int J Mol Med; 2007 Oct; 20(4):471-81. PubMed ID: 17786277 [Abstract] [Full Text] [Related]
26. Advanced glycoxidation end products in chronic diseases-clinical chemistry and genetic background. Kalousová M, Zima T, Tesar V, Dusilová-Sulková S, Skrha J. Mutat Res; 2005 Nov 11; 579(1-2):37-46. PubMed ID: 16084533 [Abstract] [Full Text] [Related]
31. Genomic damage and circulating AGE levels in patients undergoing daily versus standard haemodialysis. Fragedaki E, Nebel M, Schupp N, Sebekova K, Völkel W, Klassen A, Pischetsrieder M, Frischmann M, Niwa T, Vienken J, Heidland A, Stopper H. Nephrol Dial Transplant; 2005 Sep 11; 20(9):1936-43. PubMed ID: 15919695 [Abstract] [Full Text] [Related]
32. Further evidence of inflammation in chronic rheumatic valve disease (CRVD): high levels of advanced oxidation protein products (AOPP) and high sensitive C-reactive protein (hs-CRP). Chiu-Braga YY, Hayashi SY, Schafranski M, Messias-Reason IJ. Int J Cardiol; 2006 May 10; 109(2):275-6. PubMed ID: 15946754 [Abstract] [Full Text] [Related]
33. Advanced oxidation protein products accelerate renal fibrosis in a remnant kidney model. Li HY, Hou FF, Zhang X, Chen PY, Liu SX, Feng JX, Liu ZQ, Shan YX, Wang GB, Zhou ZM, Tian JW, Xie D. J Am Soc Nephrol; 2007 Feb 10; 18(2):528-38. PubMed ID: 17202414 [Abstract] [Full Text] [Related]
34. Effect of high-dose thiamine and pyridoxine on advanced glycation end products and other oxidative stress markers in hemodialysis patients: a randomized placebo-controlled study. Nascimento MM, Suliman ME, Murayama Y, Nihi M, Hayashi SY, Stenvinkel P, Riella MC, Lindholm B. J Ren Nutr; 2006 Apr 10; 16(2):119-24. PubMed ID: 16567267 [Abstract] [Full Text] [Related]
35. Comparison of oxidative damage in Malaysian end-stage renal disease patients with or without non-insulin-dependent diabetes mellitus. Kuppusamy UR, Indran M, Ahmad T, Wong SW, Tan SY, Mahmood AA. Clin Chim Acta; 2005 Jan 10; 351(1-2):197-201. PubMed ID: 15563890 [Abstract] [Full Text] [Related]
36. Advanced glycation end-products in patients with chronic alcohol misuse. Kalousová M, Zima T, Popov P, Spacek P, Braun M, Soukupová J, Pelinkova K, Kientsch-Engel R. Alcohol Alcohol; 2004 Jan 10; 39(4):316-20. PubMed ID: 15208163 [Abstract] [Full Text] [Related]
38. [Effects of ultrapure water on the levels of oxidative stress and inflammation parameters in maintenance hemodialysis patients]. Zhang Y, Liu J, Tao HQ, Liu ZQ, Tian JW. Nan Fang Yi Ke Da Xue Xue Bao; 2007 Sep 10; 27(9):1435-7. PubMed ID: 17884796 [Abstract] [Full Text] [Related]
39. Oxidative stresses induced by glycoxidized human or bovine serum albumin on human monocytes. Rondeau P, Singh NR, Caillens H, Tallet F, Bourdon E. Free Radic Biol Med; 2008 Sep 15; 45(6):799-812. PubMed ID: 18616999 [Abstract] [Full Text] [Related]
40. Protein oxidation status in patients with ankylosing spondylitis. Yazici C, Köse K, Calis M, Kuzugüden S, Kirnap M. Rheumatology (Oxford); 2004 Oct 15; 43(10):1235-9. PubMed ID: 15292529 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]